These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36087614)

  • 21. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis.
    Koike A; Hayashi K; Fujimori K
    Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis.
    Huaux F; Liu T; McGarry B; Ullenbruch M; Xing Z; Phan SH
    J Immunol; 2003 Nov; 171(10):5470-81. PubMed ID: 14607953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
    Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
    J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STY39, a novel alpha-melanocyte-stimulating hormone analogue, attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice.
    Xu PB; Mao YF; Meng HB; Tian YP; Deng XM
    Shock; 2011 Mar; 35(3):308-14. PubMed ID: 20926985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.
    Kamio K; Azuma A; Matsuda K; Usuki J; Inomata M; Morinaga A; Kashiwada T; Nishijima N; Itakura S; Kokuho N; Atsumi K; Hayashi H; Yamaguchi T; Fujita K; Saito Y; Abe S; Kubota K; Gemma A
    Respir Res; 2018 Apr; 19(1):71. PubMed ID: 29690905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in expression of cytokines in polyhexamethylene guanidine-induced lung fibrosis in mice: Comparison of bleomycin-induced lung fibrosis.
    Kim MS; Kim SH; Jeon D; Kim HY; Lee K
    Toxicology; 2018 Jan; 393():185-192. PubMed ID: 29175452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
    Sakamoto H; Zhao LH; Jain F; Kradin R
    Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
    Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
    Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Betulin and
    Ofori M; Danquah CA; Asante J; Ativui S; Doe P; Abdul-Nasir Taribabu A; Nugbemado IN; Mensah AN
    Heliyon; 2023 Jun; 9(6):e16914. PubMed ID: 37346329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
    Günther S; Bordenave J; Hua-Huy T; Nicco C; Cumont A; Thuillet R; Tu L; Quatremarre T; Guilbert T; Jalce G; Batteux F; Humbert M; Savale L; Guignabert C; Dinh-Xuan AT
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice.
    Zhu Y; Liu Y; Zhou W; Xiang R; Jiang L; Huang K; Xiao Y; Guo Z; Gao J
    Respir Res; 2010 Mar; 11(1):34. PubMed ID: 20302663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis.
    Arizmendi N; Puttagunta L; Chung KL; Davidson C; Rey-Parra J; Chao DV; Thebaud B; Lacy P; Vliagoftis H
    Respir Res; 2014 Jun; 15(1):71. PubMed ID: 24970330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly Selective Endothelin-1 Receptor A Inhibition Prevents Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
    Manitsopoulos N; Nikitopoulou I; Maniatis NA; Magkou C; Kotanidou A; Orfanos SE
    Respiration; 2018; 95(2):122-136. PubMed ID: 29131071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Mechanisms of Pulmonary Fibrosis with Bleomycin.
    Ishida Y; Kuninaka Y; Mukaida N; Kondo T
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
    Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
    Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cangrelor alleviates pulmonary fibrosis by inhibiting GPR17-mediated inflammation in mice.
    Zhan TW; Tian YX; Wang Q; Wu ZX; Zhang WP; Lu YB; Wu M
    Int Immunopharmacol; 2018 Sep; 62():261-269. PubMed ID: 30036769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained PI3K Activation exacerbates BLM-induced Lung Fibrosis via activation of pro-inflammatory and pro-fibrotic pathways.
    Kral JB; Kuttke M; Schrottmaier WC; Birnecker B; Warszawska J; Wernig C; Paar H; Salzmann M; Sahin E; Brunner JS; Österreicher C; Knapp S; Assinger A; Schabbauer G
    Sci Rep; 2016 Mar; 6():23034. PubMed ID: 26971883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.